Stereotaxis
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1990-01-01
- Employees
- 122
- Market Cap
- -
- Website
- http://www.stereotaxis.com
- Introduction
Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Its products include the Genesis RMN System, the Odyssey Solution, and related devices. The firm also offers the Stereotaxis Imaging Model S x-ray System. The company was founded in June 1990 and is headquartered in St. Louis, MO.
Clinical Trials
11
Trial Phases
4 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials
The MAGiC™ Cardiac Ablation European Study
- Conditions
- Arrhythmias, Cardiac
- First Posted Date
- 2023-08-31
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- Stereotaxis
- Target Recruit Count
- 150
- Registration Number
- NCT06019845
- Locations
- 🇩🇰
Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
🇱🇹Vilniaus universiteto ligoninė Santaros klinikos, Vilnius, Lithuania
RMN Versus Manual Epicardial Retrospective PMCF
- Conditions
- Ventricular TachycardiaPremature Ventricular Contraction
- First Posted Date
- 2019-11-21
- Last Posted Date
- 2023-08-03
- Lead Sponsor
- Stereotaxis
- Target Recruit Count
- 40
- Registration Number
- NCT04171479
- Locations
- 🇨🇿
Na Homolce Hospital, Prague, Czechia
🇳🇱OLVG Hospital, Amsterdam, Netherlands
🇳🇱Erasmus Medical Center, Rotterdam, Netherlands
Comparison of VT Ablation Outcomes Using Remote MAGNETIC Navigation Versus Manual Approach in a Low LVEF Population
- Conditions
- Tachycardia, Ventricular
- First Posted Date
- 2015-12-22
- Last Posted Date
- 2022-09-27
- Lead Sponsor
- Stereotaxis
- Target Recruit Count
- 182
- Registration Number
- NCT02637947
- Locations
- 🇺🇸
Florida Hospital, Orlando, Florida, United States
🇺🇸Augusta University, Augusta, Georgia, United States
🇺🇸University of Chicago Medical Center, Chicago, Illinois, United States
Vdrive Evaluation of Remote Steering and Testing in Lasso Electrophysiology Procedures Study
- Conditions
- Atrial Fibrillation
- First Posted Date
- 2012-08-03
- Last Posted Date
- 2015-07-01
- Lead Sponsor
- Stereotaxis
- Target Recruit Count
- 120
- Registration Number
- NCT01656772
- Locations
- 🇺🇸
Central Baptist Hospital, Lexington, Kentucky, United States
🇺🇸Texas Cardiac Arrhythmia Institute, Austin, Texas, United States
🇺🇸Baylor Research Institute, Dallas, Texas, United States
Stereotaxis Idiopathic Ventricular Tachycardia (VT) Study
- Conditions
- Ventricular Tachycardia
- First Posted Date
- 2011-07-25
- Last Posted Date
- 2015-05-20
- Lead Sponsor
- Stereotaxis
- Target Recruit Count
- 6
- Registration Number
- NCT01401608
- Locations
- 🇺🇸
The Ohio State University, Columbus, Ohio, United States
- Prev
- 1
- 2
- Next
News
Stereotaxis MAGiC Catheter Demonstrates 94% Acute Efficacy in First-in-Human Cardiac Ablation Study
Stereotaxis published first peer-reviewed clinical results for its MAGiC robotic magnetic navigation catheter in the Journal of Interventional Cardiac Electrophysiology.
Stereotaxis' Magbot Magnetic Ablation Catheter Approved in China
Stereotaxis received regulatory approval in China for its Magbot magnetic navigation ablation catheter, designed for minimally invasive cardiac procedures.